A randomized, multicenter, open phase II study of cetuximab with docetaxel, cisplatin as induction chemotherapy in unresectable, locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
Youngil Koh
No relevant relationships to disclose
Keun-Wook Lee
No relevant relationships to disclose
Sung-Bae Kim
No relevant relationships to disclose
Kyong Hwa Park
No relevant relationships to disclose
Sang Won Shin
No relevant relationships to disclose
Jin Hyoung Kang
No relevant relationships to disclose
Bhumsuk Keam
No relevant relationships to disclose
Se-Hoon Lee
No relevant relationships to disclose
Dae Seog Heo
No relevant relationships to disclose